SUCCESS AND FAILURE OF STRAIGHTFORWARD VERSUS SOPHISTICATED MANAGED ENTRY AGREEMENTS

被引：1
|
作者：
Van de Vijver, I [1 ]
Quanten, A. [1 ]
Knappenberg, V [1 ]
De Ridder, R. [1 ]
机构：
[1] NIHDI, Brussels, Belgium
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.885
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP336
引用
收藏
页码：A499 / A499
页数：1
相关论文
共 50 条
  • [31] Managed Entry Agreements: Policy Analysis From the European Perspective
    Dabbous, Monique
    Chachoua, Lylia
    Caban, Aleksandra
    Toumi, Mondher
    VALUE IN HEALTH, 2020, 23 (04) : 425 - 433
  • [32] Do Managed Entry Agreements Contribute to Lower Pharmaceutical Spending?
    Vokinger, Kerstin N.
    JAMA HEALTH FORUM, 2023, 4 (12):
  • [33] IMPLEMENTING MANAGED ENTRY AGREEMENTS IN PRACTICE: THE DUTCH REALITY CHECK
    Makady, A.
    van Veelen, A.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    VALUE IN HEALTH, 2017, 20 (09) : A702 - A702
  • [34] Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe
    Bouvy, Jacoline C.
    Sapede, Claudine
    Garner, Sarah
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [35] TOWARDS THE DEVELOPMENT OF MANAGED ENTRY AGREEMENTS GUIDELINES FOR HEALTH TECHNOLOGIES IN BRAZIL
    Guerra-Junior, A. A.
    Dias, C.
    Godman, B.
    Ferrario, A.
    Azevedo, P.
    Peres Gargano, L.
    de Figueiredo Zuppo, I
    Lessa Pantuzza, L.
    Barbosa de Morais Alves, C.
    Macedo do Nascimento, R. C.
    Lovato Pires de Lemos, L.
    Ribeiro, N.
    Iunes, R.
    Pippo, T.
    Curi Hauegen, R.
    Vassalo, C.
    Delgadillo, J.
    Roig, M.
    Kwon, H. Y.
    Pwu, J.
    Gambogi, R.
    Hernandez, C.
    Canuto Santos, V. C.
    Vianna, D.
    Acurcio, F. A.
    Alvares, J.
    VALUE IN HEALTH, 2020, 23 : S295 - S295
  • [36] THE USE OF MANAGED ENTRY AGREEMENTS FOR ADVANCED THERAPIES IN EU5
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S789 - S789
  • [37] THE IMPACT ON ACCESS TO INNOVATIVE DRUGS OF THE FIRST MANAGED ENTRY AGREEMENTS IN ROMANIA
    Chiriac, N. D.
    Radu, P. C.
    Pravat, M. A.
    VALUE IN HEALTH, 2016, 19 (07) : A503 - A503
  • [38] The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
    Ferrario, Alessandra
    Araja, Diana
    Bochenek, Tomasz
    Catic, Tarik
    Danko, David
    Dimitrova, Maria
    Furst, Jurij
    Greiciute-Kuprijanov, Ieva
    Hoxha, Iris
    Jakupi, Arianit
    Laidmae, Erki
    Loblova, Olga
    Mardare, Ileana
    Markovic-Pekovic, Vanda
    Meshkov, Dmitry
    Novakovic, Tanja
    Petrova, Guenka
    Pomorski, Maciej
    Tomek, Dominik
    Voncina, Luka
    Haycox, Alan
    Kanavos, Panos
    Bonanno, Patricia Vella
    Godman, Brian
    PHARMACOECONOMICS, 2017, 35 (12) : 1271 - 1285
  • [39] HOW TO DEAL WITH DECISION UNCERTAINTY? THE ITALIAN EXPERIENCE WITH MANAGED ENTRY AGREEMENTS
    Siviero, P. D.
    Sammarco, A.
    Tafuri, G.
    Pani, L.
    VALUE IN HEALTH, 2012, 15 (04) : A31 - A31
  • [40] Risk sharing in managed entry agreements-A review of the Swedish experience
    Andersson, Emelie
    Svensson, Johanna
    Persson, Ulf
    Lindgren, Peter
    HEALTH POLICY, 2020, 124 (04) : 404 - 410
12345